Pharmacokinetics of Efavirenz dosed according to the WHO weight-bands in children in Uganda.

From:
Department for International Development
Published
1 January 2010
Country:
Uganda
Document Type:
Conference Paper
Theme:
Health
Authors:
Walker, A.S., Mugyenyi, P., Gibb, D., Kekitiinwa, A., Bakeera-Kitaka, S., Burger, D., Kendall, L., Natukunda, E., Fillekes, Q., Tumusiime, C.

Abstract

As efavirenz is commonly used to treat HIV-infected children, but there is only limited data available on its pharmacokinetics in African children, this study investigated its pharmacokinetics in 41 HIV-infected children in Uganda, who were treated with doses according to their body weight as recommended by WHO. Compared to adults, the children had lower and much more variable pharmacokinetic parameters; a significant percentage had subtherapeutic levels of the drug (although others had toxic levels).

Citation

Bakeera-Kitaka, S.; Natukunda, E.; Kendall, L.; Fillekes, Q.; Kekitiinwa, A.; Tumusiime, C.; Mugyenyi, P.; Walker, A.S.; Gibb, D.; Burger, D. Pharmacokinetics of Efavirenz dosed according to the WHO weight-bands in children in Uganda. Presented at The 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, California, USA, 16-19 February 2010. (2010)

Pharmacokinetics of Efavirenz dosed according to the WHO weight-bands in children in Uganda.

Updates to this page

Published 1 January 2010
Contents